Treatment of severe chronic digoxin toxicosis in a dog with cardiac disease, using ovine digoxin-specific immunoglobulin G Fab fragments

Journal of the American Veterinary Medical Association

Volumn 215, Issue 12, 1999, Pages 1808-1812

  Ward, Deborah M ^a   Forrester, S Dru ^a   DeFrancesco, Teresa C ^b   Troy, Gregory C ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; DILTIAZEM; DIURETIC AGENT; FUROSEMIDE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; ISOPRENALINE;

ANIMAL MODEL; ANOREXIA; ARTICLE; CARDIOMYOPATHY; DIARRHEA; DIGOXIN BLOOD LEVEL; DOG; DRUG INTOXICATION; ELECTROCARDIOGRAM; FEMALE; FLUID THERAPY; HEART ARRHYTHMIA; NONHUMAN; TREATMENT OUTCOME; VETERINARY MEDICINE; VOMITING;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; DIGOXIN; DOG DISEASES; DOGS; ELECTROCARDIOGRAPHY; ENALAPRIL; FEMALE; IMMUNOGLOBULIN FAB FRAGMENTS; ISOPROTERENOL; MAGNESIUM DEFICIENCY; MAGNESIUM SULFATE;

EID: 0033572354     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Plumb DC. Veterinary drug handbook. 2nd eud. Ames, Iowa: Iowa State University Press, 1995;191-194.
2. Martiny SS, Phelps SJ, Massey KL. Treatment of severe digitalis intoxication with digoxin-specific antibody fragments: a clinical review. Crit Care Med 1988;16:629-635.
3. Smith WS. Review of clinical experience with digoxin immune Fab (ovine). Am J Emerg Med 1991;9(suppl 1):1-6.
4. Bayer MJ. Recognition and management of digitalis intoxication: implications for emergency medicine. Am J Emerg Med 1991;9(suppl 1):29-32.
5. Amman EM, Wenger TL, Butler VP, et al. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicemer study. Circulation 1990;81:1744-1752.
6. Spiegel A, Marchlinski FE. Time course for reversal of digoxin toxicity with digoxin-specific antibody fragments. Am Heart J 1985;109:1397-1399.
7. Butler VP, Schmidt DH, Smith TW, et al. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. J Clin Invest 1977;59:345-359.
8. Ochs HR, Vatner SF, Smith TW. Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog. J Pharmacol Exp Ther 1978;207:64-71.
9. Senior DF, Feist EH, Stuart LB, et al. Treatment of acute digoxin toxicosis with digoxin immune Fab (ovine). J Vet Intern Med 1991;5:302-303.
10. Digibind (package insert). Beckenham, England: The Wellcome Foundation Ltd, 1994;1-4.
11. Teske RH, Bishop SR Righter HF et al. Subacute digoxin toxicosis in the beagle dog. Toxicol Appl Pharmacol 1976;35:283-301.
12. Natowicz M, Shaw L. Digoxin assay anomalies due to digoxin-specific Fab immunotherapy. DICP 1991;25:739-741.
13. Gibb I, Adams PC, Parnham AJ, et al. Plasma digoxin: assay anomalies in Fab-treated patients. Br J Clin Pharmacol 1983;16: 445-447.
14. Ujhelyi MR, Cummings DM, Green P, et al. Effect of digoxin Fab antibodies on five digoxin immunoassays. Ther Drug Monit 1990;12:288-292.
15. Honda SA, Rios CN, Murakami L, et al. Problems in determining levels of free digoxin in patients treated with digoxin immune Fab. J Clin Lab Anal 1995;9:407-412.
16. Rainey PM. Effects of digoxin immune Fab (ovine) on digoxin immunoassays. Am J Clin Pathol 1989;92:779-786.
17. Dhupa N. Magnesium therapy. In: Bonagura JD, ed. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995:132-133.
18. Martin LG, Van Pelt DR, Wingfield WE. Magnesium and the critically ill patient. In: Bonagura JD, ed. Kirk's current veterinary therapy XII. Philadelphia: WB Saunders Co, 1995:128-131.
19. Cobb M, Michell AR. Plasma electrolyte concentrations in dogs receiving diuretic therapy for cardiac failure. J Small Anim Pract 1992;33:526-529.